Expression of a Truncated Form of the c-Kit Tyrosine Kinase Receptor and Activation of Src Kinase in Human Prostatic Cancer
- 1 April 2004
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 164 (4), 1243-1251
- https://doi.org/10.1016/s0002-9440(10)63212-9
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- tr-kit promotes the formation of a multimolecular complex composed by Fyn, PLCγ1 and Sam68Oncogene, 2003
- Characterization of a Novel Negative Regulator (DOC-2/DAB2) of c-Src in Normal Prostatic Epithelium and CancerPublished by Elsevier ,2003
- Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive MalignanciesJournal of Clinical Oncology, 2002
- Truncated ErbB2 receptor enhances ErbB1 signaling and induces reversible, ERK-independent loss of epithelial morphologyInternational Journal of Cancer, 2001
- Alterations in the focal adhesion kinase/Src signal transduction pathway correlate with increased migratory capacity of prostate carcinoma cellsOncogene, 2001
- Neoplastic Transformation and Tumorigenesis Associated with Sam68 Protein Deficiency in Cultured Murine FibroblastsJournal of Biological Chemistry, 2000
- Overexpression of the Hepatocyte Growth Factor (HGF) Receptor (Met) and Presence of a Truncated and Activated Intracellular HGF Receptor Fragment in Locally Aggressive/Malignant Human Musculoskeletal TumorsThe American Journal of Pathology, 2000
- CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASESAnnual Review of Cell and Developmental Biology, 1997
- Expression and identification of aberrant c-kit transcripts in human cancer cellsCancer Letters, 1997
- An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosisNature, 1994